A major driver of high drug prices is the lack of value consciousness on the part of prescribing physicians.

Despite fiduciary rule's demise, plan sponsors will demand fiduciary services, says Janus Henderson Investors VP Matt Sommer.

Lotteries and cold calling share two characteristics: The cost is minimal and the payoff is substantial.

Promises by the pharmaceutical industry to contain prices are a familiar — and fleeting — phenomenon, say analysts.